AMRN(AMRN)
AMRN
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $182M | $193M | $188M | $234M |
| Low | $172M | $183M | $178M | $222M |
| High | $192M | $203M | $199M | $247M |
| EBITDA Avg | $-33M | $-34M | $-34M | $-42M |
| Low | $-34M | $-36M | $-35M | $-44M |
| High | $-31M | $-33M | $-32M | $-40M |
| EBIT Avg | $-34M | $-36M | $-36M | $-44M |
| Low | $-36M | $-38M | $-37M | $-47M |
| High | $-33M | $-34M | $-34M | $-42M |
| Net Income Avg | $-726,221.5 | $1M | $1M | $4M |
| Low | $-776,741 | $1M | $-829,968 | $4M |
| High | $-675,702 | $1M | $4M | $4M |
| EPS Avg | $-0.04 | $0.06 | $0.07 | $0.19 |
| Low | $-0.04 | $0.05 | $-0.04 | $0.18 |
| High | $-0.03 | $0.06 | $0.17 | $0.20 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 2 / 2 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $44M | $49M | $39M |
| Low | $44M | $49M | $39M |
| High | $44M | $49M | $39M |
| EBITDA Avg | $-8M | $-9M | $-7M |
| Low | $-8M | $-9M | $-7M |
| High | $-8M | $-9M | $-7M |
| EBIT Avg | $-8M | $-9M | $-7M |
| Low | $-8M | $-9M | $-7M |
| High | $-8M | $-9M | $-7M |
| Net Income Avg | $-104,000 | $104,000 | $-208,000 |
| Low | $-104,051 | $103,948 | $-208,103 |
| High | $-103,948 | $104,051 | $-207,896 |
| EPS Avg | $-0.01 | $0.01 | $-0.01 |
| Low | $-0.01 | $0.00 | $-0.01 |
| High | $-0.00 | $0.01 | $-0.01 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |